We are live on ! Find out more
ONC

BeOne Medicines Ltd

238 hedge funds and large institutions have $10.4B invested in BeOne Medicines Ltd in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 99 increasing their positions, 78 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $14M

27% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 78

0.04% less ownership

Funds ownership: 4.17%4.13% (-0.04%)

9% less funds holding

Funds holding: 262238 (-24)

17% less funds holding in top 10

Funds holding in top 10: 1210 (-2)

31% less capital invested

Capital invested by funds: $15B → $10.4B (-$4.65B)

48% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 42

Holders
238
Holders Change
-24
Holders Change %
-9.16%
% of All Funds
3.75%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.16%
New
22
Increased
99
Reduced
78
Closed
42
Calls
$23.6M
Puts
$14M
Net Calls
+$9.69M
Net Calls Change
+$106M
Name Holding Trade Value Shares
Change
Change in
Stake
CIS
26
Capital International Sarl
California
$32.6M +$10.2M +47,918 +38%
BNP Paribas Asset Management
27
BNP Paribas Asset Management
France
$31.5M +$205K +966 +0.6%
PCIG
28
Partners Capital Investment Group
Massachusetts
$28.9M +$7.82M +36,794 +32%
CC
29
Casdin Capital
New York
$28.3M
Swiss National Bank
30
Swiss National Bank
Switzerland
$24.3M +$3.38M +15,900 +14%
Mitsubishi UFJ Trust & Banking
31
Mitsubishi UFJ Trust & Banking
Japan
$24M -$1.78M -8,392 -6%
Morgan Stanley
32
Morgan Stanley
New York
$22.2M -$7.83M -36,815 -24%
JP Morgan Chase
33
JP Morgan Chase
New York
$22M -$4.11M -19,336 -14%
CS
34
Credit Suisse
Switzerland
$21.8M +$1.24M +5,827 +5%
Sumitomo Mitsui Trust Group
35
Sumitomo Mitsui Trust Group
Japan
$20.6M +$640K +3,012 +3%
Northern Trust
36
Northern Trust
Illinois
$20.1M -$1.58M -7,421 -6%
UIM
37
USS Investment Management
United Kingdom
$20M -$23.5M -110,512 -51%
Amundi
38
Amundi
France
$19.3M +$302K +1,420 +2%
Deutsche Bank
39
Deutsche Bank
Germany
$19.3M -$2.74M -12,879 -11%
Mirae Asset Global Investments
40
Mirae Asset Global Investments
South Korea
$18.6M -$3.37M -15,832 -14%
N
41
Nuveen
North Carolina
$18.1M +$5.51M +25,900 +37%
Baird Financial Group
42
Baird Financial Group
Wisconsin
$17.7M +$1.91M +8,967 +11%
VanEck Associates
43
VanEck Associates
New York
$17.6M +$9.02M +42,417 +83%
UBS Group
44
UBS Group
Switzerland
$15.9M +$8.54M +40,148 +90%
HSBC Holdings
45
HSBC Holdings
United Kingdom
$15.8M +$1.72M +8,083 +11%
Vanguard Group
46
Vanguard Group
Pennsylvania
$15.8M +$902K +4,245 +5%
AQR Capital Management
47
AQR Capital Management
Connecticut
$14.7M -$155K -729 -0.9%
PAMS
48
Pictet Asset Management (Switzerland)
Switzerland
$14.5M -$28.2M -132,558 -63%
Wellington Management Group
49
Wellington Management Group
Massachusetts
$14.1M -$144M -675,876 -90%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$14M +$5.11M +24,020 +48%

ONC Hedge Fund Activity: Q1 2022 in Review

238 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2022, worth a combined $10.4B — down 31% from $15B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ONC and 22 opened new positions — a net loss of 20 holders — while 78 trimmed existing stakes and 99 added.

The largest buyer was Capital International Investors, adding an estimated $151M. The largest seller was Wellington Management Group, cutting an estimated $144M.

  • 238 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2022, down from 262 in Q4 2021.
  • Funds reported $10.4B of BeOne Medicines Ltd stock for Q1 2022, down 31% quarter-over-quarter.
  • 22 funds opened new BeOne Medicines Ltd positions in Q1 2022 and 42 closed out, a net change of -20 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2022 was Capital International Investors, an estimated $151M added.
  • The largest BeOne Medicines Ltd seller in Q1 2022 was Wellington Management Group, an estimated $144M sold.

Based on aggregated 13F filings for Q1 2022.